Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Minimal clinically important difference--exacerbations of COPD.

Calverley PM.

COPD. 2005 Mar;2(1):143-8. Review.

PMID:
17136975
2.

Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.

Sobieraj DM, White CM, Coleman CI.

Clin Ther. 2008 Aug;30(8):1416-25. doi: 10.1016/j.clinthera.2008.08.004.

PMID:
18803985
3.

Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis.

Puhan MA, Bachmann LM, Kleijnen J, Ter Riet G, Kessels AG.

BMC Med. 2009 Jan 14;7:2. doi: 10.1186/1741-7015-7-2.

4.

Validation and clinical interpretation of the St George's Respiratory Questionnaire among COPD patients, China.

Xu W, Collet JP, Shapiro S, Lin Y, Yang T, Wang C, Bourbeau J.

Int J Tuberc Lung Dis. 2009 Feb;13(2):181-9.

PMID:
19146745
5.

Challenges associated with estimating minimal clinically important differences in COPD-the NHLBI perspective.

Kiley JP, Sri Ram J, Croxton TL, Weinmann GG.

COPD. 2005 Mar;2(1):43-6. Review.

PMID:
17136960
6.
7.

Effect of exacerbations on health status in subjects with chronic obstructive pulmonary disease.

Nishimura K, Sato S, Tsukino M, Hajiro T, Ikeda A, Koyama H, Oga T.

Health Qual Life Outcomes. 2009 Jul 22;7:69. doi: 10.1186/1477-7525-7-69.

8.

Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?

Soler-Cataluña JJ, Rodriguez-Roisin R.

COPD. 2010 Aug;7(4):276-84. doi: 10.3109/15412555.2010.496817. Review.

PMID:
20673037
9.

Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline.

Wilt TJ, Niewoehner D, MacDonald R, Kane RL.

Ann Intern Med. 2007 Nov 6;147(9):639-53. Review.

PMID:
17975187
10.

St. George's Respiratory Questionnaire: MCID.

Jones PW.

COPD. 2005 Mar;2(1):75-9.

PMID:
17136966
11.

Counting, analysing and reporting exacerbations of COPD in randomised controlled trials.

Aaron SD, Fergusson D, Marks GB, Suissa S, Vandemheen KL, Doucette S, Maltais F, Bourbeau JF, Goldstein RS, Balter M, O'Donnell D, Fitzgerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.

Thorax. 2008 Feb;63(2):122-8. Epub 2007 Aug 16. Review.

PMID:
17702790
12.

[Trial end-point in chronic obstructive pulmonary disease (COPD): minimal clinically important difference].

Gillissen A, Buhl R, Kardos P, Puhan M, Rabe KF, Rothe T, Sauer R, Welte T, Worth H, Menz G.

Pneumologie. 2008 Mar;62(3):149-55. doi: 10.1055/s-2007-996182. Review. German.

PMID:
18320495
13.

The 2007 GOLD Guidelines: a comprehensive care framework.

Gold PM.

Respir Care. 2009 Aug;54(8):1040-9. Review. Erratum in: Respir Care. 2009 Nov;54(11):1501.

16.

Efficacy of tiotropium in the prevention of exacerbations of COPD.

Anzueto A, Miravitlles M.

Ther Adv Respir Dis. 2009 Jun;3(3):103-11. doi: 10.1177/1753465809338854. Epub 2009 Jul 17. Review.

PMID:
19617284
17.

Correlation of frequency of exacerbations with the BODE index in COPD patients.

Hodgev VA, Kostianev SS, Marinov BA.

Folia Med (Plovdiv). 2006;48(2):18-22.

PMID:
17408072
18.
19.

Managing stable COPD in 2009: incorporating results from recent clinical studies into a goal-directed approach for clinicians.

Rubins JB, Raci E, Kunisaki KM.

Postgrad Med. 2009 Jan;121(1):104-12. doi: 10.3810/pgm.2009.01.1959. Review.

PMID:
19179818
20.

Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodology.

Seemungal T, Stockley R, Calverley P, Hagan G, Wedzicha JA.

COPD. 2007 Sep;4(3):177-83.

PMID:
17729060

Supplemental Content

Support Center